BERLIN-CHEMIE develops, produces and sells pharmaceutical products. BERLIN-CHEMIE is a German subsidiary of the MENARINI Group, which has been occupying a leading position in the Italian pharmaceutical market for many years. The company, which was formed in 1886 and is headquartered in Florence, was developed over the generations to become a global, owner-managed pharmaceutical company.
MENARINI pursues two strategic objectives: research and internationalisation. Both endeavours enable innovative products to be used successfully to the satisfaction of patients throughout the world. The MENARINI Group enjoys an outstanding reputation worldwide as an efficient and reliable partner. This applies both to the development of new drugs and to the communication of scientific insights.
BERLIN-CHEMIE also benefits from this partnership-based way of thinking. We consistently carry on the group strategy in our remit.
- Berlin-Chemie/Menarini Germany
- Berlin-Chemie/Menarini International
Our research is centred on the development of innovative drugs for the following areas:
- Inflammatory diseases and pain
- Cardiovascular diseases
- Viral disease